Knowing how to stop: Ceasing prescribing when the medicine is no longer required

Journal of Managed Care Pharmacy

Volumn 18, Issue 1, 2012, Pages 68-72

  Ostini, Remo ^a   Hegney, Desley ^a   Jackson, Claire ^a   Tett, Susan E ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; MEDICAL SCHOOL; MEDICAL STUDENT; NOTE; PHARMACEUTICAL CARE; PHARMACIST; POLYPHARMACY; PRESCRIPTION; QUASI EXPERIMENTAL STUDY;

EID: 84860718870     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2012.18.1.68     Document Type: Note

References (64)

1. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56(10):1946- Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119470/?tool=pubmed. Accessed November 25, 2011.
2. Simons J. A world of hurt. Fortune. 2005;151(1):17-18.
3. Alexander GC, Sayla MA, Holmes HM, Sachs GA. Prioritizing and stopping prescription medicines. CMAJ. 2006;174(8):1083-84. Available at: http://www.cmaj.ca/content/174/8/1083.full.pdf+html. Accessed November 25, 2011.
4. de Vries TP, Henning RH, Hogerziel HV, Fresle DA. Guide to Good Prescribing: A Practical Manual. 2nd ed. Geneva: World Health Organization; 1994. Available at: http://www.who.int/medicinedocs/pdf/whozip23e/whozip23e.pdf. Accessed November 25, 2011.
5. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician's Guide. 2nd ed. New York: McGraw-Hill;2004.
6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.
7. Ostini R, Jackson C, Hegney D, Tett SE. How is medication prescribing ceased? A systematic review. Med Care. 2011;49(1):24-36.
8. Bailey TC, Ritchie DJ, McMullin ST, et al. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy. 1997;17(2):277-81.
9. Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44(386):408-12. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1238990/?tool=pubmed. Accessed November 25, 2011.
10. Gleason PP, Solberg CL, Brelje TV, Hartwig SC, Wadd W. Assessment of a retrospective drug utilization review alert letter program. J Clin Outcomes Manag. 2004;11(3):150-54.
11. Gorgels WJ, Oude Voshaar RC, Mol A, et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend. 2005;78(1):49-56.
12. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly. A controlled trial of physcian feedback. J Am Geriatr Soc. 1990;38(1):31-36.
13. Krol N, Wensing M, Haaijer-Ruskamp F, et al. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial. Aliment Pharmacol Ther. 2004;19(8):917-22. Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2004.01928.x/abstract;jsessionid=DA57569FB2C37933CA8E1B63C0096163.d03t01. Accessed November 25, 2011.
14. Midmer D, Kahan M, Marlow B. Effects of a distance learning program on physicians' opioid- and benzodiazepine-prescribing skills. J Contin Educ Health Prof. 2006;26(4):294-301.
15. Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003;168(7):835-39. Available at: http://www.cmaj.ca/content/168/7/835.long. Accessed November 25, 2011.
16. Roumie CL, Elasy TA, Wallston KA, et al. Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf. 2007;33(5):277-85.
17. Stewart R, Niessen WJ, Broer J, Snijders TA, Haaijer-Ruskamp FM, Meyboom-De Jong B. General practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application. J Clin Epidemiol. 2007;60(10):1076-84.
18. Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169(6):549- Available at: http://www.cmaj.ca/content/169/6/549.long. Accessed November 25, 2011.
19. Zullich SG, Grasela Jr TH, Fiedler-Kelly JB, Gengo FM. Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities. Ann Pharmacother. 1992;26(4):539-46.
20. Gill PS, Mäkelä M, Vermeulen KM, et al. Changing doctor prescribing behaviour. Pharm World Sci. 1999;21(4):158-67.
21. Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother. 2006;40(9):1546-57.
22. Ostini R, Hegney D, Jackson C, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43(3):502-13.
23. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021-31.
24. Plumridge RJ. A review of factors influencing drug prescribing (Part 2). Aust J Hosp Pharm. 1983;13:44-48.
25. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-34.
26. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q. 1989;67(2):268-317.
27. Iglesias JE, Rocks K, Jahanshad N, Frias-Martinez E, Andrada LP, Bui AA. Tracking medication information across medical records. AMIA Annu Symp Proc. 2009:266-70.
28. Decker C, Garavalia L, Garavalia B, Spertus JA. Clopidogrel-taking behavior by drug-eluting stent patients: discontinuers versus continuers. Patient Prefer Adherence. 2008;2:167-75. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770390/?tool=pubmed. Accessed November 25, 2011.
29. Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments. Health Mark Q. 2006;22(4):73-107.
30. Gallan AS. Factors that influence physicians' prescribing of pharmaceuticals: a literature review. J Pharm Mark Manag. 2005;16(4):3-46.
31. McDonnell Norms Group. Antibiotic overuse: the influence of social norms. J Am Coll Surg. 2008;207(2):265-75.
32. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19-34.
33. Ostini R, Hegney D, Mackson JM, Williamson M, Tett SE. Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiol Drug Saf. 2008;17(11):1077-90.
34. Ruggiero C, Lattanzio F, Dell'Aquila G, Gasperini B, Cherubini A. Inappropriate drug prescriptions among older nursing home residents: the Italian perspective. Drugs Aging. 2009;26(Suppl 1):15-30.
35. Comer JS, Olfson M, Mojtabai R. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1001-10. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952543/?tool=pmcentrez. Accessed November 25, 2011.
36. Hovstadius B, Hovstadius K, Åstrand B, Petersson G. Increasing polypharmacy- an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10:16. Available at: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC3014875/pdf/1472-6904-10-16.pdf. Accessed November 25, 2011.
37. National Audit Office. Repeat prescribing by general medical practitioners in England. August 11, 1993. Available at: http://www.official-documents.gov.uk/document/hc9293/hc08/0897/0897.pdf. Accessed November 25, 2011.
38. National Audit Office. GP prescribing behaviour 2006: report into the findings of a survey of General Practitioners in England. 2006. Available at: http://www.nao.org.uk/idoc.ashx?docId=b520f6bd-4bbb-42f6-8b6a-0ddc43d59a54&version=-1. Accessed November 25, 2011.
39. Feely J, Chan R, McManus J, O'Shea B. The influence of hospitalbased prescribers on prescribing in general practice. Pharmacoeconomics. 1999;16(2):175-81.
40. Squizzato A, Keller T, Middeldorp S. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev. 2007;(3):CD 005158.
41. Antoniou S, Rothman MT. Stent thrombosis: patient card on discontinuing clopidogrel is available. BMJ. 2007;334(7584):57. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767303/pdf/bmj-334-7584-ltr-0057a.pdf?tool=pmcentrez. Accessed November 25, 2011.
42. Pham CQD, Sadowski-Hayes LM, Regal RE. Prevalent prescribing of proton pump inhibitors: prudent or pernicious? P and T. 2006;31(3):159-67.
43. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011;36(1):33-44.
44. Moen J, Antonov K, Larsson CA, et al. Factors associated with multiple medication use in different age groups. Ann Pharmacother. 2009;43(12):1978-85.
45. Banerjee A, Mbamalu D, Ebrahimi S, Khan AA, Chan TF. The prevalence of polypharmacy in elderly attenders to an emergency department - a problem with a need for an effective solution. Int J Emerg Med. 2011;4(1):22. Available at: http://www.intjem.com/content/pdf/1865-1380-4-22.pdf. Accessed November 25, 2011.
46. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019-28.
47. Constantine RJ, Boaz T, Tandon R. Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state Medicaid program. Clin Ther. 2010;32(5):949-59.
48. Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175-88.
49. Poeschla BD, Bartle P, Hansen KP. Serotonin syndrome associated with polypharmacy in the elderly. Gen Hosp Psychiatry. 2011;33(3):301.
50. Cherubini A, Ruggiero C, Gasperini B, et al. The prevention of adverse drug reactions in older subjects. Curr Drug Metab. 2011;12(7):652-57.
51. Kojima T, Akishita M, Nakamura T, et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int. 2011;11(4):438-44.
52. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a populationbased study. Medicine (Baltimore). 2010;89(5):295-99.
53. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging. 2011;28(4):315-23.
54. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039-48.
55. Fillit H, Futterman R, Orland BI, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care. 1999;5(5):587-94.
56. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428-37.
57. Pugh MJ, Rosen AK, Montez-Rath M, et al. Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level. Med Care. 2008;46(2):167-73.
58. Kaufman MB, Brodin KA, Sarafian A. Effect of prescriber education on the use of medications contraindicated in older adults in a managed medicare population. J Manag Care Pharm. 2005;11(3):211-19. Available at: http://www.amcp.org/data/jmcp/Research_211-219.pdf.
59. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007;55(7):977-85.
60. Fick DM, Maclean JR, Rodriguez NA, et al. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag Care. 2004;10(11 Pt1):761-68.
61. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA. 1998;280(14):1249-52. Available at: http://jama.ama-assn.org/content/280/14/1249.long. Accessed November 25, 2011.
62. Zonfrillo MR, Penn JV, Leonard HL. Pediatric psychotropic polypharmacy. Psychiatry (Edgmont). 2005;2(8):14-19. Available at: http://www. ncbi.nlm.nih.gov/pmc/articles/PMC3000211/pdf/PE_2_8_14.pdf. Accessed November 25, 2011.
63. Bronskill SE, Gill SS, Paterson JM, Bell CM, Anderson GM, Rochon PA. Exploring variation in rates of polypharmacy across long-term care homes. J Am Med Dir Assoc. 2011 Aug 2011 [Epub ahead of print].
64. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;8(1):63-72.